ExtendicarePMZ receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Extendicare Inc (EXE)
Extendicare Inc stock price live, this page displays TSX EXE stock exchange data. View the EXE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Extendicare Inc real time stock price chart below.
What Is the Extendicare Inc Stock Price Today?
The Extendicare Inc stock price today is 26.29.
What Is the Stock Symbol for Extendicare Inc?
The stock symbol for Extendicare Inc is ""EXE.""
What Stock Exchange Does Extendicare Inc Trade On?
Extendicare Inc is listed and trades on the Toronto stock exchange.
Is Extendicare Inc a Good Stock to Buy?
Determining whether Extendicare Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EXE quote. (ISIN: CA30224T8639) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
What Is the Extendicare Inc Stock Price Today?
The Extendicare Inc stock price today is 26.29.
What Is the Stock Symbol for Extendicare Inc?
The stock symbol for Extendicare Inc is ""EXE.""
What Stock Exchange Does Extendicare Inc Trade On?
Extendicare Inc is listed and trades on the Toronto stock exchange.
Is Extendicare Inc a Good Stock to Buy?
Determining whether Extendicare Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EXE quote. (ISIN: CA30224T8639) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
26.29
-0.09(-0.34%)
Closed·
Fair Value
An estimate of a Extendicare Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.52
26.52
52 wk Range
12.12
27.56
EXE is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a Extendicare Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.5226.52
52 wk Range
12.1227.56
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.92%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.92%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
EXE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Extendicare Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
31.28
Upside
+18.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Cash flows can sufficiently cover interest payments
- ExtendicarePMZ receives Investment Bank Analyst Rating Update
- Investing.com
Pro - ExtendicarePMZ receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- ExtendicarePMZ receives Investment Bank Analyst Rating Update
- Investing.com
Pro - ExtendicarePMZ receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Extendicare Inc Company Profile
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties and joint ventures. It provides its services under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. The company was incorporated in 1968 and is based in Markham, Canada.
Extendicare Inc Earnings Call Summary for Q4/2025
- Q4 EPS of CAD 0.286 beat forecasts by 41.65%; revenue rose 18% YoY to CAD 462M, missing estimates by 4.83%; stock surged 10.38% to CAD 24.15
- Adjusted EBITDA climbed 36.4% YoY to CAD 45.6M; AFFO per share increased 6% to CAD 0.337; payout ratio stood at 42% for the quarter
- Strong performance driven by strategic acquisitions and organic growth in Home Health Care and Long-Term Care segments amid aging demographics
- FY2026 EPS guidance set at CAD 8.7, FY2027 at CAD 8.78; revenue projected at CAD 10,016M and CAD 9,928M respectively for both years
- Management highlighted robust cash position and expanded credit facilities to fund strategic initiatives; cited regulatory changes and labor costs as key risks
Last Updated: 27/02/2026, 18:48
Read Full TranscriptCompare EXE to Peers and Sector
Metrics to compare | EXE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEXEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.0x | 5.0x | −0.5x | |
PEG Ratio | 0.85 | 0.01 | 0.00 | |
Price/Book | 6.5x | 0.8x | 2.6x | |
Price / LTM Sales | 1.5x | 0.7x | 3.2x | |
Upside (Analyst Target) | 18.0% | 10.5% | 51.4% | |
Fair Value Upside | Unlock | 13.1% | 8.5% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 31.28
(+18.97% Upside)
Earnings
Latest Release
Feb 26, 2026
EPS / Forecast
0.286 / 0.2019
Revenue / Forecast
462.03M / 485.50M
People Also Watch
FAQ
What Is the Extendicare Inc (EXE) Stock Price Today?
The Extendicare Inc stock price today is 26.29 CAD.
What Stock Exchange Does Extendicare Inc Trade On?
Extendicare Inc is listed and trades on the Toronto Stock Exchange.
What Is the Stock Symbol for Extendicare Inc?
The stock symbol for Extendicare Inc is "EXE."
What Is the Extendicare Inc Market Cap?
As of today, Extendicare Inc market cap is 2.48B CAD.
What Is Extendicare Inc's Earnings Per Share (TTM)?
The Extendicare Inc EPS (TTM) is 1.13.
When Is the Next Extendicare Inc Earnings Date?
Extendicare Inc will release its next earnings report on May 13, 2026.
From a Technical Analysis Perspective, Is EXE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Extendicare Inc Stock Split?
Extendicare Inc has split 0 times.
How Many Employees Does Extendicare Inc Have?
Extendicare Inc has 23500 employees.
What is the current trading status of Extendicare Inc (EXE)?
As of Mar 06, 2026, Extendicare Inc (EXE) is trading at a price of 26.29 CAD, with a previous close of 26.38 CAD. The stock has fluctuated within a day range of 25.52 CAD to 26.52 CAD, while its 52-week range spans from 12.12 CAD to 27.56 CAD.
What Is Extendicare Inc (EXE) Price Target According to Analysts?
The average 12-month price target for Extendicare Inc is 31.28 CAD, with a high estimate of 35 CAD and a low estimate of 30 CAD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +18.97% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.